Casing, Villano G.
HRN: 22-07-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2022
CEFTRIAXONE 1G (VIAL)
10/18/2022
10/24/2022
IVTT
2g
Q24
Erythematous And Ulcerative Wound With Purulent Discharges
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes